Integrated Diagnostics announced this week the appointment of Donald Seaton as its chief financial officer and James Garner as its chief business officer.
Seaton brings to the company more than two decades of experience as a biotech executive and was previously the chief financial officer and chief operating officer at EndoGastric Solutions. Garner, meanwhile, has been consulting Integrated Diagnostics for more than a year. Prior to joining the company, Garner was senior VP of global sales and i3 research at UnitedHealth Group.
With these appointments, Integrated Diagnostics has fully formed its executive team, the company said.
UK-based Lab21 has appointed Fraser Logue as the company's group director of quality, regulatory affairs and operations excellence. Previously, Logue worked within various divisions of Abbott Laboratories. Most recently, he was division VP of worldwide manufacturing of Abbott's diabetes care division.